25, 35 and 45 West Watkins Mill Road, Gaithersburg, MD |
WASHINGTON, DC, July 28,
2015 – Holliday Fenoglio Fowler, L.P. (HFF) announced today that it has closed
the sale of and arranged financing for 25, 35 and 45 West Watkins Mill Road,
three office/lab buildings totaling 139,938 square feet in the Washington, D.C.
submarket of Gaithersburg, Maryland.
Jim Meisel |
HFF represented the
seller, an affiliate of Equus Capital Partners, Ltd., in the transaction. Tritower Financial Group purchased the assets
for $29.4 million and was assisted by HFF in securing a 10-year, fixed-rate
acquisition loan with a life insurance company.
25, 35 and 45 West Watkins
Mill Road are situated on a combined 12.7 acres within Montgomery County’s
I-270 corridor, which is widely known as a leading life sciences center.
The properties are within
walking distance of the new Watkins Mill Town Center and have easy access to
area roadways including Rockville Pike, Routes 117 and 124 and the Intercounty
Connector.
Tenants at the 95 percent,
triple net leased buildings include MedImmune and Amplimmune, wholly owned
subsidiaries of AstraZeneca.
The HFF investment sales
team representing the seller included senior managing directors Jim Meisel, Dek Potts and Andrew Weir,
executive managing director Stephen
Conley and associate director Matthew
Nicholson.
HFF’s debt placement team
representing the new owner was led by managing director Cary Abod.
For a complete copy of the company’s news release,
please contact:
Kristen M. Murphy
Associate Director
HFF | One Post Office
Square, Suite 3500 | Boston, MA 02109
Main: 617-338-0990 |
Direct: 617-848-1572 | Cell: 617-543-4873 | www.hfflp.com